Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Description

The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder.

Official source

Eligible beneficiaries

• For profit organizations other than small businesses
• City or township governments
• Private institutions of higher education
• County governments
• State governments
• Native American tribal organizations (other than Federally recognized tribal governments)
• Small businesses
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Public housing authorities/Indian housing authorities
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Independent school districts
• Native American tribal governments (Federally recognized)
• Public and State controlled institutions of higher education
• Special district governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)